Soluble adhesion molecules in human cancers: Sources and fates

European Journal of Cell Biology

Volumn 89, Issue 6, 2010, Pages 415-427

  van Kilsdonk, Jeroen W J ^a   van Kempen, Léon C L T ^b   van Muijen, Goos N P ^b   Ruiter, Dirk J ^b   Swart, Guido W M ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adhesion molecules; Ectodomain shedding; Ectosomes; Exosomes; Metastasis; Proteases; Soluble adhesion molecules; Tumor progression; Vesicles

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ADAM PROTEIN; CADHERIN; CD147 ANTIGEN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; MATRIX METALLOPROTEINASE; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE L1; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEINASE; UVOMORULIN;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; CANCER CELL; CANCER GROWTH; CELL ADHESION; CELL FUNCTION; CELL VACUOLE; EXOSOME; FUNCTIONAL PROTEOMICS; GENE EXPRESSION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MEMBRANE VESICLE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TRANSPORT; SHORT SURVEY; TUMOR VASCULARIZATION;

CELL ADHESION; CELL ADHESION MOLECULES; CELL COMMUNICATION; CELL MOVEMENT; DISEASE PROGRESSION; HUMANS; NEOPLASMS;

EID: 77951937223     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2009.11.026     Document Type: Short Survey

References (190)

1. Admyre C., Johansson S.M., Qazi K.R., Filen J.J., Lahesmaa R., Norman M., Neve E.P., Scheynius A., Gabrielsson S. Exosomes with immune modulatory features are present in human breast milk. J. Immunol. 2007, 179(3). 1969-1978. 1-8-2007.
2. Ahrens T., Sleeman J.P., Schempp C.M., Howells N., Hofmann M., Ponta H., Herrlich P., Simon J.C. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid. Oncogene 2001, 20(26):3399-3408.
3. Allory Y., Matsuoka Y., Bazille C., Christensen E.I., Ronco P., Debiec H. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Clin. Cancer Res. 2005, 11(3):1190-1197.
4. Anderegg U., Eichenberg T., Parthaune T., Haiduk C., Saalbach A., Milkova L., Ludwig A., Grosche J., Averbeck M., Gebhardt C., Voelcker V., Sleeman J.P., Simon J.C. ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells. J. Invest Dermatol. 2009, 129(6):1471-1482.
5. Andre F., Schartz N.E., Movassagh M., Flament C., Pautier P., Morice P., Pomel C., Lhomme C., Escudier B., Le Chevalier T., Tursz T., Amigorena S., Raposo G., Angevin E., Zitvogel L. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 2002, 360(9329):295-305.
6. Andreola G., Rivoltini L., Castelli C., Huber V., Perego P., Deho P., Squarcina P., Accornero P., Lozupone F., Lugini L., Stringaro A., Molinari A., Arancia G., Gentile M., Parmiani G., Fais S. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med. 2002, 195(10):1303-1316.
7. Angst B.D., Marcozzi C., Magee A.I. The cadherin superfamily: diversity in form and function. J. Cell Sci. 2001, 114(Pt 4):629-641.
8. Arribas J., Bech-Serra J.J., Santiago-Josefat B. ADAMs, cell migration and cancer. Cancer Metastasis Rev. 2006, 25(1):57-68.
9. Arribas J., Borroto A. Protein ectodomain shedding. Chem. Rev. 2002, 102(12):4627-4638.
10. Baciu P.C., Suleiman E.A., Deryugina E.I., Strongin A.Y. Membrane type-1 matrix metalloproteinase (MT1-MMP) processing of pro-alphav integrin regulates cross-talk between alphavbeta3 and alpha2beta1 integrins in breast carcinoma cells. Exp. Cell Res. 2003, 291(1):167-175.
11. Baj-Krzyworzeka M., Szatanek R., Weglarczyk K., Baran J., Urbanowicz B., Branski P., Ratajczak M.Z., Zembala M. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol. Immunother. 2006, 55(7):808-818.
12. Bard M.P., Hegmans J.P., Hemmes A., Luider T.M., Willemsen R., Severijnen L.A., van Meerbeeck J.P., Burgers S.A., Hoogsteden H.C., Lambrecht B.N. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am. J. Respir. Cell Mol. Biol. 2004, 31(1):114-121.
13. Bauer R., Bosserhoff A.K. Functional implication of truncated P-cadherin expression in malignant melanoma. Exp. Mol. Pathol. 2006, 81(3):224-230.
14. Bauer R., Hein R., Bosserhoff A.K. A secreted form of P-cadherin is expressed in malignant melanoma. Exp. Cell Res. 2005, 305(2):418-426.
15. Bech-Serra J.J., Santiago-Josefat B., Esselens C., Saftig P., Baselga J., Arribas J., Canals F. Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis. Mol. Cell Biol. 2006, 26(13):5086-5095.
16. Becker J.W., Marcy A.I., Rokosz L.L., Axel M.G., Burbaum J.J., Fitzgerald P.M., Cameron P.M., Esser C.K., Hagmann W.K., Hermes J.D. Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Protein Sci. 1995, 4(10):1966-1976.
17. Beer S., Oleszewski M., Gutwein P., Geiger C., Altevogt P. Metalloproteinase-mediated release of the ectodomain of L1 adhesion molecule. J. Cell Sci. 1999, 112(Pt 16):2667-2675.
18. Belkin A.M., Akimov S.S., Zaritskaya L.S., Ratnikov B.I., Deryugina E.I., Strongin A.Y. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J. Biol. Chem. 2001, 276(21):18415-18422.
19. Belkin A.M., Zemskov E.A., Hang J., Akimov S.S., Sikora S., Strongin A.Y. Cell-surface-associated tissue transglutaminase is a target of MMP-2 proteolysis. Biochemistry 2004, 43(37):11760-11769.
20. Bidard F.C., Pierga J.Y., Vincent-Salomon A., Poupon M.F. A "class action" against the microenvironment: do cancer cells cooperate in metastasis?. Cancer Metastasis Rev. 2008, 27(1):5-10.
21. Billion K., Ibrahim H., Mauch C., Niessen C.M. Increased soluble E-cadherin in melanoma patients. Skin Pharmacol. Physiol 2006, 19(2):65-70.
22. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., Cerretti D.P. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997, 385(6618):729-733.
23. Blobel C.P. ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 2005, 6(1):32-43.
24. Bogenrieder T., Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 2003, 22(42):6524-6536.
25. Bowen M.A., Aruffo A.A., Bajorath J. Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions. Proteins 2000, 40(3):420-428.
26. Brummendorf T., Kenwrick S., Rathjen F.G. Neural cell recognition molecule L1: from cell biology to human hereditary brain malformations. Curr. Opin. Neurobiol. 1998, 8(1):87-97.
27. Caby M.P., Lankar D., Vincendeau-Scherrer C., Raposo G., Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int. Immunol. 2005, 17(7):879-887.
28. Calzolari A., Raggi C., Deaglio S., Sposi N.M., Stafsnes M., Fecchi K., Parolini I., Malavasi F., Peschle C., Sargiacomo M., Testa U. TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. J. Cell Sci. 2006, 119(Pt 21):4486-4498.
29. Chirco R., Liu X.W., Jung K.K., Kim H.R. Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev. 2006, 25(1):99-113.
30. Choi D.S., Lee J.M., Park G.W., Lim H.W., Bang J.Y., Kim Y.K., Kwon K.H., Kwon H.J., Kim K.P., Gho Y.S. Proteomic analysis of microvesicles derived from human colorectal cancer cells. J. Proteome. Res. 2007, 6(12):4646-4655.
31. Chunthapong J., Seftor E.A., Khalkhali-Ellis Z., Seftor R.E., Amir S., Lubaroff D.M., Heidger P.M., Hendrix M.J. Dual roles of E-cadherin in prostate cancer invasion. J. Cell Biochem. 2004, 91(4):649-661.
32. Clayton A., Mitchell J.P., Court J., Mason M.D., Tabi Z. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res. 2007, 67(15):7458-7466.
33. Clayton A., Turkes A., Dewitt S., Steadman R., Mason M.D., Hallett M.B. Adhesion and signaling by B cell-derived exosomes: the role of integrins. FASEB J. 2004, 18(9):977-979.
34. Conacci-Sorrell M., Kaplan A., Raveh S., Gavert N., Sakurai T., Ben Ze'ev A. The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation. Cancer Res. 2005, 65(24):11605-11612.
35. Conacci-Sorrell M., Zhurinsky J., Ben Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J. Clin. Invest 2002, 109(8):987-991.
36. Covington M.D., Burghardt R.C., Parrish A.R. Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Am. J. Physiol Renal Physiol 2006, 290(1):F43-F51.
37. Davies G., Jiang W.G., Mason M.D. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin. Cancer Res. 2001, 7(10):3289-3297.
38. De Angelis E., MacFarlane J., Du J.S., Yeo G., Hicks R., Rathjen F.G., Kenwrick S., Brummendorf T. Pathological missense mutations of neural cell adhesion molecule L1 affect homophilic and heterophilic binding activities. EMBO J. 1999, 18(17):4744-4753.
39. De Angelis E., Watkins A., Schafer M., Brummendorf T., Kenwrick S. Disease-associated mutations in L1 CAM interfere with ligand interactions and cell-surface expression. Hum. Mol. Genet. 2002, 11(1):1-12.
40. De Wever, O., Derycke, L., Hendrix, A., De Meerleer, G., Godeau, F., Depypere, H., and Bracke, M., 2007. Soluble cadherins as cancer biomarkers. Clin. Exp. Metastasis.
41. Degen W.G., van Kempen L.C., Gijzen E.G., van Groningen J.J., van Kooyk Y., Bloemers H.P., Swart G.W. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule). Am. J. Pathol. 1998, 152(3):805-813.
42. Demetriou M.C., Pennington M.E., Nagle R.B., Cress A.E. Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. Exp. Cell Res. 2004, 294(2):550-558.
43. Deregibus M.C., Cantaluppi V., Calogero R., Lo Iacono M., Tetta C., Biancone L., Bruno S., Bussolati B., Camussi G. Endothelial progenitor cell-derived microvesicles activate an angiogenic program in endothelial cells by an horizontal transfer of mRNA. Blood 2007.
44. Derycke L., De Wever O., Stove V., Vanhoecke B., Delanghe J., Depypere H., Bracke M. Soluble N-cadherin in human biological fluids. Int. J. Cancer 2006, 119(12):2895-2900.
45. Derycke L., Morbidelli L., Ziche M., De Wever O., Bracke M., Van Aken E. Soluble N-cadherin fragment promotes angiogenesis. Clin. Exp. Metastasis 2006, 23(3-4):187-201.
46. Deryugina E.I., Bourdon M.A., Jungwirth K., Smith J.W., Strongin A.Y. Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int. J. Cancer 2000, 86(1):15-23.
47. Deryugina E.I., Ratnikov B.I., Postnova T.I., Rozanov D.V., Strongin A.Y. Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J. Biol. Chem. 2002, 277(12):9749-9756.
48. Dolo V., D'Ascenzo S., Violini S., Pompucci L., Festuccia C., Ginestra A., Vittorelli M.L., Canevari S., Pavan A. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin. Exp. Metastasis 1999, 17(2):131-140.
49. Dolo V., Ginestra A., Cassara D., Violini S., Lucania G., Torrisi M.R., Nagase H., Canevari S., Pavan A., Vittorelli M.L. Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res. 1998, 58(19):4468-4474.
50. Egawa N., Koshikawa N., Tomari T., Nabeshima K., Isobe T., Seiki M. Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells. J. Biol. Chem. 2006, 281(49):37576-37585.
51. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2(3):161-174.
52. Feltes C.M., Kudo A., Blaschuk O., Byers S.W. An alternatively spliced cadherin-11 enhances human breast cancer cell invasion. Cancer Res. 2002, 62(22):6688-6697.
53. Fiore E., Fusco C., Romero P., Stamenkovic I. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene 2002, 21(34):5213-5223.
54. Fitzgerald M.L., Wang Z., Park P.W., Murphy G., Bernfield M. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J. Cell Biol. 2000, 148(4):811-824.
55. Fogel M., Gutwein P., Mechtersheimer S., Riedle S., Stoeck A., Smirnov A., Edler L., Ben Arie A., Huszar M., Altevogt P. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 2003, 362(9387):869-875.
56. Fogel M., Mechtersheimer S., Huszar M., Smirnov A., Abu-Dahi A., Tilgen W., Reichrath J., Georg T., Altevogt P., Gutwein P. L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma. Cancer Lett. 2003, 189(2):237-247.
57. Friedl P., Maaser K., Klein C.E., Niggemann B., Krohne G., Zanker K.S. Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of alpha2 and beta1 integrins and CD44. Cancer Res. 1997, 57(10):2061-2070.
58. Gadducci A., Ferdeghini M., Cosio S., Annicchiarico C., Fanucchi A., Prontera C., Bianchi R., Genazzani A.R. The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer. Anticancer Res. 1998, 18(1B):537-539.
59. Gadducci A., Ferdeghini M., Fanucchi A., Annicchiarico C., Cosio S., Prontera C., Bianchi R., Genazzani A.R. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer. Anticancer Res. 1997, 17(6D):4463-4466.
60. Garton K.J., Gough P.J., Raines E.W. Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J. Leukoc. Biol. 2006, 79(6):1105-1116.
61. Gasbarri A., Del Prete F., Girnita L., Martegani M.P., Natali P.G., Bartolazzi A. CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage. Melanoma Res. 2003, 13(4):325-337.
62. Gavert N., Conacci-Sorrell M., Gast D., Schneider A., Altevogt P., Brabletz T., Ben Ze'ev A. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J.Cell Biol. 2005, 168(4):633-642.
63. Ginestra A., La Placa M.D., Saladino F., Cassara D., Nagase H., Vittorelli M.L. The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res. 1998, 18(5A):3433-3437.
64. Ginestra A., Monea S., Seghezzi G., Dolo V., Nagase H., Mignatti P., Vittorelli M.L. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J. Biol. Chem. 1997, 272(27):17216-17222.
65. Goldberger A., Middleton K.A., Oliver J.A., Paddock C., Yan H.C., DeLisser H.M., Albelda S.M., Newman P.J. Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. J. Biol. Chem. 1994, 269(25):17183-17191.
66. Graves L.E., Ariztia E.V., Navari J.R., Matzel H.J., Stack M.S., Fishman D.A. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res. 2004, 64(19):7045-7049.
67. Gutwein P., Mechtersheimer S., Riedle S., Stoeck A., Gast D., Joumaa S., Zentgraf H., Fogel M., Altevogt D.P. ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J. 2003, 17(2):292-294.
68. Gutwein P., Oleszewski M., Mechtersheimer S., Agmon-Levin N., Krauss K., Altevogt P. Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells. J. Biol. Chem. 2000, 275(20):15490-15497.
69. Gutwein P., Stoeck A., Riedle S., Gast D., Runz S., Condon T.P., Marme A., Phong M.C., Linderkamp O., Skorokhod A., Altevogt P. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin. Cancer Res. 2005, 11(7):2492-2501.
70. Haass N.K., Smalley K.S., Li L., Herlyn M. Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res. 2005, 18(3):150-159.
71. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(1):57-70.
72. Haug C., Lenz C., Diaz F., Bachem M.G. Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase Inducer (EMMPRIN) release by coronary smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2004, 24(10):1823-1829.
73. Hawari F.I., Rouhani F.N., Cui X., Yu Z.X., Buckley C., Kaler M., Levine S.J. Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. Proc. Natl. Acad. Sci. U.S.A 2004, 101(5):1297-1302.
74. Hayashido Y., Hamana T., Yoshioka Y., Kitano H., Koizumi K., Okamoto T. Plasminogen activator/plasmin system suppresses cell-cell adhesion of oral squamous cell carcinoma cells via proteolysis of E-cadherin. Int. J. Oncol. 2005, 27(3):693-698.
75. Heaney M.L., Golde D.W. Soluble receptors in human disease. J. Leukoc. Biol. 1998, 64(2):135-146.
76. Hegmans J.P., Bard M.P., Hemmes A., Luider T.M., Kleijmeer M.J., Prins J.B., Zitvogel L., Burgers S.A., Hoogsteden H.C., Lambrecht B.N. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am. J. Pathol. 2004, 164(5):1807-1815.
77. Hofmann U.B., Houben R., Brocker E.B., Becker J.C. Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 2005, 87(3-4):307-314.
78. Hofmann U.B., Westphal J.R., Zendman A.J., Becker J.C., Ruiter D.J., van Muijen G.N. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. J. Pathol. 2000, 191(3):245-256.
79. Hortsch M. The L1 family of neural cell adhesion molecules: old proteins performing new tricks. Neuron 1996, 17(4):587-593.
80. Hortsch M. Structural and functional evolution of the L1 family: are four adhesion molecules better than one?. Mol.Cell Neurosci. 2000, 15:1.
81. Howard L., Maciewicz R.A., Blobel C.P. Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28. Biochem. J. 2000, 348(Pt 1):21-27.
82. Huber V., Fais S., Iero M., Lugini L., Canese P., Squarcina P., Zaccheddu A., Colone M., Arancia G., Gentile M., Seregni E., Valenti R., Ballabio G., Belli F., Leo E., Parmiani G., Rivoltini L. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 2005, 128(7):1796-1804.
83. Hugel B., Martinez M.C., Kunzelmann C., Freyssinet J.M. Membrane microparticles: two sides of the coin. Physiology.(Bethesda.) 2005, 20:22-27.
84. Ikeda K., Quertermous T. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function. J. Biol. Chem. 2004, 279(53):55315-55323.
85. Ishiwata N., Takio K., Katayama M., Watanabe K., Titani K., Ikeda Y., Handa M. Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule. J. Biol. Chem. 1994, 269(38):23708-23715.
86. Itoh T., Tanioka M., Matsuda H., Nishimoto H., Yoshioka T., Suzuki R., Uehira M. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin. Exp. Metastasis. 1999, 17(2):177-181.
87. Jiang Y., Goldberg I.D., Shi Y.E. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 2002, 21(14):2245-2252.
88. Johnson S.K., Ramani V.C., Hennings L., Haun R.S. Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer 2007, 109(9):1811-1820.
89. Jung T., Castellana D., Klingbeil P., Hernandez I.C., Vitacolonna M., Orlicky D.J., Roffler S.R., Brodt P., Zoller M. CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia. 2009, 11(10):1093-1105.
90. Kajita M., Itoh Y., Chiba T., Mori H., Okada A., Kinoh H., Seiki M. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 2001, 153(5):893-904.
91. Kang T., Zhao Y.G., Pei D., Sucic J.F., Sang Q.X. Intracellular activation of human adamalysin 19/disintegrin and metalloproteinase 19 by furin occurs via one of the two consecutive recognition sites. J. Biol. Chem. 2002, 277(28):25583-25591.
92. Katayama M., Iwamatsu A., Masutani H., Furuke K., Takeda K., Wada H., Masuda T., Ishii K. Expression of neural cell adhesion molecule L1 in human lung cancer cell lines. Cell Struct. Funct. 1997, 22(5):511-516.
93. Keller S., Konig A.K., Marme F., Runz S., Wolterink S., Koensgen D., Mustea A., Sehouli J., Altevogt P. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett. 278 2009, 1(73-81):8-6-2009.
94. Keller S., Rupp C., Stoeck A., Runz S., Fogel M., Lugert S., Hager H.D., Abdel-Bakky M.S., Gutwein P., Altevogt P. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int. 2007, 72(9):1095-1102.
95. Keller S., Sanderson M.P., Stoeck A., Altevogt P. Exosomes: from biogenesis and secretion to biological function. Immunol. Lett. 2006, 107(2):102-108.
96. Kim C.W., Lee H.M., Lee T.H., Kang C., Kleinman H.K., Gho Y.S. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res. 2002, 62(21):6312-6317.
97. Kim H., Koh G. Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway. Biochem. Biophys. Res. Commun. 2000, 269(2):401-405.
98. King J.A., Ofori-Acquah S.F., Stevens T., Al Mehdi A.B., Fodstad O., Jiang W.G. Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res. 2004, 6(5):R478-R487.
99. Klucky B., Mueller R., Vogt I., Teurich S., Hartenstein B., Breuhahn K., Flechtenmacher C., Angel P., Hess J. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion. Cancer Res. 2007, 67(17):8198-8206.
100. Kristiansen G., Pilarsky C., Wissmann C., Kaiser S., Bruemmendorf T., Roepcke S., Dahl E., Hinzmann B., Specht T., Pervan J., Stephan C., Loening S., Dietel M., Rosenthal A. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J. Pathol. 2005, 205(3):359-376.
101. Kristiansen G., Pilarsky C., Wissmann C., Stephan C., Weissbach L., Loy V., Loening S., Dietel M., Rosenthal A. ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate 2003, 54(1):34-43.
102. Levine S.J. Mechanisms of soluble cytokine receptor generation. J. Immunol. 2004, 173(9):5343-5348.
103. Li X.B., Zhang Z.R., Schluesener H.J., Xu S.Q. Role of exosomes in immune regulation. J. Cell Mol. Med. 2006, 10(2):364-375.
104. Lum L., Reid M.S., Blobel C.P. Intracellular maturation of the mouse metalloprotease disintegrin MDC15. J. Biol. Chem. 1998, 273(40):26236-26247.
105. Lunter P.C., van Kilsdonk J.W., van Beek H., Cornelissen I.M., Bergers M., Willems P.H., van Muijen G.N., Swart G.W. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity. Cancer Res. 2005, 65(19):8801-8808.
106. Lynch C.C., Matrisian L.M. Matrix metalloproteinases in tumor-host cell communication. Differentiation 2002, 70(9-10):561-573.
107. Ma Y., Visser L., Roelofsen H., de Vries M., Diepstra A., van Imhoff G., van der Wal T., Luinge M., Alvarez-Llamas G., Vos H., Poppema S., Vonk R., van den Berg A. Proteomics analysis of Hodgkin lymphoma: Identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes. Blood 2007.
108. Maetzel D., Denzel S., Mack B., Canis M., Went P., Benk M., Kieu C., Papior P., Baeuerle P.A., Munz M., Gires O. Nuclear signalling by tumour-associated antigen EpCAM. Nat. Cell Biol. 2009, 11(2):162-171.
109. Mareel M., Boterberg T., Noe V., Van Hoorde L., Vermeulen S., Bruyneel E., Bracke M. E-cadherin/catenin/cytoskeleton complex: a regulator of cancer invasion. J. Cell Physiol 1997, 173(2):271-274.
110. Maretzky T., Reiss K., Ludwig A., Buchholz J., Scholz F., Proksch E., de Strooper B., Hartmann D., Saftig P. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc. Natl. Acad. Sci. U.S.A 2005, 102(26):9182-9187.
111. Maretzky T., Schulte M., Ludwig A., Rose-John S., Blobel C., Hartmann D., Altevogt P., Saftig P., Reiss K. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Mol. Cell Biol. 2005, 25(20):9040-9053.
112. Mayer C., Maaser K., Daryab N., Zanker K.S., Brocker E.B., Friedl P. Release of cell fragments by invading melanoma cells. Eur. J. Cell Biol. 2004, 83(11-12):709-715.
113. McGuire J.K., Li Q., Parks W.C. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am. J. Pathol. 2003, 162(6):1831-1843.
114. Mears R., Craven R.A., Hanrahan S., Totty N., Upton C., Young S.L., Patel P., Selby P.J., Banks R.E. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics. 2004, 4(12):4019-4031.
115. Mechtersheimer S., Gutwein P., Agmon-Levin N., Stoeck A., Oleszewski M., Riedle S., Postina R., Fahrenholz F., Fogel M., Lemmon V., Altevogt P. Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J. Cell Biol. 2001, 155(4):661-673.
116. Meier F., Busch S., Gast D., Goppert A., Altevogt P., Maczey E., Riedle S., Garbe C., Schittek B. The adhesion molecule L1 (CD171) promotes melanoma progression. Int. J. Cancer 2006, 119(3):549-555.
117. Meli M.L., Carrel F., Waibel R., Amstutz H., Crompton N., Jaussi R., Moch H., Schubiger P.A., Novak-Hofer I. Anti-neuroblastoma antibody chCE7 binds to an isoform of L1-CAM present in renal carcinoma cells. Int. J. Cancer 1999, 83(3):401-408.
118. Miles, F.L., Pruitt, F.L., van Golen, K.L., and Cooper, C.R., 2007. Stepping out of the flow: capillary extravasation in cancer metastasis. Clin. Exp. Metastasis.
119. Millimaggi D., Mari M., D'Ascenzo S., Carosa E., Jannini E.A., Zucker S., Carta G., Pavan A., Dolo V. Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia. 2007, 9(4):349-357.
120. Monea S., Jordan B.A., Srivastava S., DeSouza S., Ziff E.B. Membrane localization of membrane type 5 matrix metalloproteinase by AMPA receptor binding protein and cleavage of cadherins. J. Neurosci. 2006, 26(8):2300-2312.
121. Murai T., Miyazaki Y., Nishinakamura H., Sugahara K.N., Miyauchi T., Sako Y., Yanagida T., Miyasaka M. Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. J. Biol. Chem. 2004, 279(6):4541-4550.
122. Nagano O., Murakami D., Hartmann D., de Strooper B., Saftig P., Iwatsubo T., Nakajima M., Shinohara M., Saya H. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J. Cell Biol. 2004, 165(6):893-902.
123. Nagano O., Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci. 2004, 95(12):930-935.
124. Nakamura H., Suenaga N., Taniwaki K., Matsuki H., Yonezawa K., Fujii M., Okada Y., Seiki M. Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase. Cancer Res. 2004, 64(3):876-882.
125. Naor D., Sionov R.V., Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 1997, 71:241-319.
126. Nawrocki-Raby B., Gilles C., Polette M., Bruyneel E., Laronze J.Y., Bonnet N., Foidart J.M., Mareel M., Birembaut P. Upregulation of MMPs by soluble E-cadherin in human lung tumor cells. Int. J. Cancer 2003, 105(6):790-795.
127. Nayeem N., Silletti S., Yang X., Lemmon V.P., Reisfeld R.A., Stallcup W.B., Montgomery A.M. A potential role for the plasmin(ogen) system in the posttranslational cleavage of the neural cell adhesion molecule L1. J. Cell Sci. 1999, 112(Pt 24):4739-4749.
128. Noe V., Fingleton B., Jacobs K., Crawford H.C., Vermeulen S., Steelant W., Bruyneel E., Matrisian L.M., Mareel M. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J. Cell Sci 2001, 114(Pt 1):111-118.
129. Okamoto I., Kawano Y., Murakami D., Sasayama T., Araki N., Miki T., Wong A.J., Saya H. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J. Cell Biol. 2001, 155(5):755-762.
130. Okamoto I., Tsuiki H., Kenyon L.C., Godwin A.K., Emlet D.R., Holgado-Madruga M., Lanham I.S., Joynes C.J., Vo K.T., Guha A., Matsumoto M., Ushio Y., Saya H., Wong A.J. Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am. J. Pathol. 2002, 160(2):441-447.
131. Paradies N.E., Grunwald G.B. Purification and characterization of NCAD90, a soluble endogenous form of N-cadherin, which is generated by proteolysis during retinal development and retains adhesive and neurite-promoting function. J. Neurosci. Res. 1993, 36(1):33-45.
132. Paschke K.A., Lottspeich F., Stuermer C.A. Neurolin, a cell surface glycoprotein on growing retinal axons in the goldfish visual system, is reexpressed during retinal axonal regeneration. J. Cell Biol. 1992, 117(4):863-875.
133. Pawar S.C., Demetriou M.C., Nagle R.B., Bowden G.T., Cress A.E. Integrin alpha6 cleavage: a novel modification to modulate cell migration. Exp. Cell Res. 2007, 313(6):1080-1089.
134. Peduzzi J.D., Irwin M.H., Geisert E.E. Jr. Distribution and characteristics of a 90 kDa protein, KG-CAM, in the rat CNS. Brain Res. 1994, 640(1-2):296-307.
135. Peschon J.J., Slack J.L., Reddy P., Stocking K.L., Sunnarborg S.W., Lee D.C., Russell W.E., Castner B.J., Johnson R.S., Fitzner J.N., Boyce R.W., Nelson N., Kozlosky C.J., Wolfson M.F., Rauch C.T., Cerretti D.P., Paxton R.J., March C.J., Black R.A. An essential role for ectodomain shedding in mammalian development. Science 1998, 282(5392):1281-1284.
136. Piazza T., Cha E., Bongarzone I., Canevari S., Bolognesi A., Polito L., Bargellesi A., Sassi F., Ferrini S., Fabbi M. Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody. J. Cell Sci 2005, 118(Pt 7):1515-1525.
137. Porter S., Clark I.M., Kevorkian L., Edwards D.R. The ADAMTS metalloproteinases. Biochem. J 2005, 386(Pt 1):15-27.
138. Primakoff P., Myles D.G. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet. 2000, 16(2):83-87.
139. Ratajczak J., Miekus K., Kucia M., Zhang J., Reca R., Dvorak P., Ratajczak M.Z. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006, 20(5):847-856.
140. Ratajczak J., Wysoczynski M., Hayek F., Janowska-Wieczorek A., Ratajczak M.Z. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20(9):1487-1495.
141. Ratnikov B.I., Rozanov D.V., Postnova T.I., Baciu P.G., Zhang H., DiScipio R.G., Chestukhina G.G., Smith J.W., Deryugina E.I., Strongin A.Y. An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase. J.Biol.Chem. 2002, 277(9):7377-7385.
142. Reiss K., Ludwig A., Saftig P. Breaking up the tie: disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion. Pharmacol.Ther. 2006, 111(3):985-1006.
143. Reiss K., Maretzky T., Ludwig A., Tousseyn T., de Strooper B., Hartmann D., Saftig P. ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling. EMBO J. 2005, 24(4):742-752.
144. Roghani M., Becherer J.D., Moss M.L., Atherton R.E., Erdjument-Bromage H., Arribas J., Blackburn R.K., Weskamp G., Tempst P., Blobel C.P. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J. Biol. Chem. 1999, 274(6):3531-3540.
145. Rosso O., Piazza T., Bongarzone I., Rossello A., Mezzanzanica D., Canevari S., Orengo A.M., Puppo A., Ferrini S., Fabbi M. The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells. Mol. Cancer Res. 2007, 5(12):1246-1253.
146. Roy R., Zhang B., Moses M.A. Making the cut: protease-mediated regulation of angiogenesis. Exp. Cell Res. 2006, 312(5):608-622.
147. Runz, S., Keller, S., Rupp, C., Stoeck, A., Issa, Y., Koensgen, D., Mustea, A., Sehouli, J., Kristiansen, G., and Altevogt, P.,2007. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol. Oncol.
148. Ryniers F., Stove C., Goethals M., Brackenier L., Noe V., Bracke M., Vandekerckhove J., Mareel M., Bruyneel E. Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion. Biol. Chem. 2002, 383(1):159-165.
149. Sawhney M., Matta A., Macha M.A., Kaur J., DattaGupta S., Shukla N.K., Ralhan R. Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients. Int. J. Cancer. 2009, 124(9):2098-2105.
150. Seals D.F., Courtneidge S.A. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 2003, 17(1):7-30.
151. Segura E., Nicco C., Lombard B., Veron P., Raposo G., Batteux F., Amigorena S., Thery C. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood 2005, 106(1):216-223.
152. Senner V., Kismann E., Puttmann S., Hoess N., Baur I., Paulus W. L1 expressed by glioma cells promotes adhesion but not migration. Glia 2002, 38(2):146-154.
153. Sidhu S.S., Mengistab A.T., Tauscher A.N., LaVail J., Basbaum C. The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 2004, 23(4):956-963.
154. Smalley K.S., Haass N.K., Brafford P.A., Lioni M., Flaherty K.T., Herlyn M. Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases. Mol. Cancer Ther. 2006, 5(5):1136-1144.
155. Staubach S., Razawi H., Hanisch F.G. Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7. Proteomics. 2009, 9(10):2820-2835.
156. Stoeck A., Gast D., Sanderson M.P., Issa Y., Gutwein P., Altevogt P. L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecol. Oncol. 2007, 104(2):461-469.
157. Stoeck A., Keller S., Riedle S., Sanderson M.P., Runz S., Le Naour F., Gutwein P., Ludwig A., Rubinstein E., Altevogt P. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem. J 2006, 393(Pt 3):609-618.
158. Stone A.L., Kroeger M., Sang Q.X. Structure-function analysis of the ADAM family of disintegrin-like and metalloproteinase-containing proteins (review). J. Protein Chem. 1999, 18(4):447-465.
159. Subramaniam V., Gardner H., Jothy S. Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells. Exp. Mol. Pathol. 2007, 83(3):341-346.
160. Suyama K., Shapiro I., Guttman M., Hazan R.B. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2002, 2(4):301-314.
161. Swart G.W. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration. Eur.J.Cell Biol. 2002, 81(6):313-321.
162. Swart G.W., Lunter P.C., Kilsdonk J.W., Kempen L.C. Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?. Cancer Metastasis Rev. 2005, 24(2):223-236.
163. Symowicz J., Adley B.P., Gleason K.J., Johnson J.J., Ghosh S., Fishman D.A., Hudson L.G., Stack M.S. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Cancer Res. 2007, 67(5):2030-2039.
164. Tang Y., Kesavan P., Nakada M.T., Yan L. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol. Cancer Res 2004, 2(2):73-80.
165. Taraboletti G., D'Ascenzo S., Borsotti P., Giavazzi R., Pavan A., Dolo V. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am. J. Pathol. 2002, 160(2):673-680.
166. Taraboletti G., D'Ascenzo S., Giusti I., Marchetti D., Borsotti P., Millimaggi D., Giavazzi R., Pavan A., Dolo V. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia. 2006, 8(2):96-103.
167. Taylor D.D., Gercel-Taylor C. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br. J. Cancer 2005, 92(2):305-311.
168. Taylor P.M., Woodfield R.J., Hodgkin M.N., Pettitt T.R., Martin A., Kerr D.J., Wakelam M.J. Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A(2) and 5-lipoxygenase catalyzed pathway. Oncogene 2002, 21(37):5765-5772.
169. Thery C., Boussac M., Veron P., Ricciardi-Castagnoli P., Raposo G., Garin J., Amigorena S. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 2001, 166(12):7309-7318.
170. Thery C., Regnault A., Garin J., Wolfers J., Zitvogel L., Ricciardi-Castagnoli P., Raposo G., Amigorena S. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J. Cell Biol. 1999, 147(3):599-610.
171. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2002, 2(8):569-579.
172. Thies A., Schachner M., Moll I., Berger J., Schulze H.J., Brunner G., Schumacher U. Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. Eur. J. Cancer 2002, 38(13):1708-1716.
173. Tomita K., van Bokhoven A., Jansen C.F., Bussemakers M.J., Schalken J.A. Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin. Biochem. Biophys. Res. Commun. 2000, 267(3):870-874.
174. Tousseyn T., Jorissen E., Reiss K., Hartmann D. (Make) stick and cut loose--disintegrin metalloproteases in development and disease. Birth Defects Res. C. Embryo. Today 2006, 78(1):24-46.
175. Utton M.A., Eickholt B., Howell F.V., Wallis J., Doherty P. Soluble N-cadherin stimulates fibroblast growth factor receptor dependent neurite outgrowth and N-cadherin and the fibroblast growth factor receptor co-cluster in cells. J. Neurochem. 2001, 76(5):1421-1430.
176. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9(6):654-659.
177. Valenti R., Huber V., Iero M., Filipazzi P., Parmiani G., Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res. 2007, 67(7):2912-2915.
178. van Kempen L.C., van den Oord J.J., van Muijen G.N., Weidle U.H., Bloemers H.P., Swart G.W. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am. J. Pathol. 2000, 156(3):769-774.
179. van Kilsdonk J.W., Wilting R.H., Bergers M., van Muijen G.N., Schalkwijk J., van Kempen L.C., Swart G.W. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule. Cancer Res. 2008, 68(10):3671-3679.
180. van Niel G., Porto-Carreiro I., Simoes S., Raposo G. Exosomes: a common pathway for a specialized function. J. Biochem.(Tokyo) 2006, 140:1.
181. Van Wart H.E., Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U.S.A 1990, 87(14):5578-5582.
182. Verma A., Shukla N.K., Deo S.V., Gupta S.D., Ralhan R. MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma. Oncology 2005, 68(4-6):462-470.
183. von Bredow D.C., Nagle R.B., Bowden G.T., Cress A.E. Cleavage of beta 4 integrin by matrilysin. Exp. Cell Res. 1997, 236(1):341-345.
184. Weichert W., Knosel T., Bellach J., Dietel M., Kristiansen G. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J. Clin. Pathol. 2004, 57(11):1160-1164.
185. Wieckowski E.U., Visus C., Szajnik M., Szczepanski M.J., Storkus W.J., Whiteside T.L. Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J. Immunol. 2009, 183(6):3720-3730.
186. Witkowska A.M., Borawska M.H. Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. Eur. Cytokine Netw. 2004, 15(2):91-98.
187. Wubbolts R., Leckie R.S., Veenhuizen P.T., Schwarzmann G., Mobius W., Hoernschemeyer J., Slot J.W., Geuze H.J., Stoorvogel W. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J. Biol. Chem. 2003, 278(13):10963-10972.
188. Yan L., Zucker S., Toole B.P. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb. Haemost. 2005, 93(2):199-204.
189. Yu Q., Toole B.P. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44. J. Biol. Chem. 1996, 271(34):20603-20607.
190. Zhang G., Slaughter C., Humphries E.H. v-rel Induces ectopic expression of an adhesion molecule, DM-GRASP, during B-lymphoma development. Mol. Cell Biol. 1995, 15(3):1806-1816.